Serum Lactate Dehydrogenase Isoenzyme 1: An Early Indicator Of Relapse In Patients With Testicular Germ Cell Tumors

Authors

  • Finn Edler Eyben Department of Internal Medicine, Stensby Hospital, Minnesund, Norway
  • E. Lindegaard Madsen Department of Internal Medicine, Stensby Hospital, Minnesund, Norway
  • O. Blaabjerg Department of Internal Medicine, Stensby Hospital, Minnesund, Norway
  • P. Hyltoft Petersen Department of Internal Medicine, Stensby Hospital, Minnesund, Norway

DOI:

https://doi.org/10.3109/02841869509127206

Abstract

The present study aimed to evaluate serum lactate dehydrogenase isoenzyme 1 (S-LD-1) as an indicator of relapse for patients with testicular germ cell tumors. Twenty-seven patients were investigated with repeated determinations of S-LD-1 from diagnosis to relapse; 9 had seminoma and 18 nonseminomatous tumors. Eleven of 21 had raised S-LD-1 at relapse (4 with seminoma). Seven of the 27 patients had a raised S-LD-1 for median 2 months (1.4–4.5 months) before relapse was detected. Thus, S-LD-1 is of use, complementary to clinical examinations, determinations of serum alpha fetoprotein and human chorionic gonadotropin, and CT scans, in monitoring patients with testicular germ cell tumors for relapse.

Downloads

Download data is not yet available.

Downloads

Published

1995-01-01

How to Cite

Edler Eyben, F., Lindegaard Madsen, E., Blaabjerg, O., & Hyltoft Petersen, P. (1995). Serum Lactate Dehydrogenase Isoenzyme 1: An Early Indicator Of Relapse In Patients With Testicular Germ Cell Tumors. Acta Oncologica, 34(7), 925–929. https://doi.org/10.3109/02841869509127206

Issue

Vol. 34 No. 7 (1995): Acta Oncologica

Section

Articles